Immix Biopharma, Inc.
IMMXAs of the close on Sep 25, 2026
Price
$10.97
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Immix Biopharma, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| FOX RUN MANAGEMENT, L.L.C. | 2026-03-31 | 20,693 | Not shown | SEC filing |
| TritonPoint Partners, LLC | 2026-03-31 | 24,526 | Not shown | SEC filing |
| Velan Capital Investment Management LP | 2026-03-31 | 740,000 | Not shown | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 44,490 | Not shown | SEC filing |
| Blue Owl Capital Holdings LP | 2026-03-31 | 547,552 | Not shown | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 27,462 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 471,394 | Not shown | SEC filing |
| Imprint Wealth LLC | 2026-03-31 | 31,248 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 1,750,200 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 463,384 | Not shown | SEC filing |
| LGT Fund Management Co Ltd. | 2026-03-31 | 416,594 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 51,768 | Not shown | SEC filing |
| Virtu Financial LLC | 2026-03-31 | 48,109 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 35,164 | Not shown | SEC filing |
| Bleichroeder LP | 2026-03-31 | 1,000,000 | Not shown | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 17,817 | Not shown | SEC filing |
| Logos Global Management LP | 2026-03-31 | 1,225,000 | Not shown | SEC filing |
| Kera Capital Partners, Inc. | 2026-03-31 | 13,000 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 41,131 | Not shown | SEC filing |
| CITIGROUP INC | 2026-03-31 | 2,464 | Not shown | SEC filing |
- Each value is checked against Immix Biopharma, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- SBI Securities Co., Ltd.: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- Private Advisor Group, LLC: 31,725 shares reported 2025-12-31; 34,725 shares reported 2026-03-31.
- MARSHALL WACE, LLP: 1,978,743 shares reported 2025-12-31; 1,641,552 shares reported 2026-03-31.
- Allworth Financial LP: 5,716 shares reported 2025-12-31; 7,245 shares reported 2026-03-31.
- STATE STREET CORP: 97,360 shares reported 2025-12-31; 191,910 shares reported 2026-03-31.
- JPMORGAN CHASE & CO: 5,109 shares reported 2025-12-31; 2,537 shares reported 2026-03-31.
- MORGAN STANLEY: 126,622 shares reported 2025-12-31; 139,886 shares reported 2026-03-31.
- UNITED CAPITAL FINANCIAL ADVISORS, LLC: 70,682 shares reported 2025-12-31; 70,682 shares reported 2026-03-31.
- FRANKLIN RESOURCES INC: 980,392 shares reported 2025-12-31; 969,066 shares reported 2026-03-31.
- BNP PARIBAS FINANCIAL MARKETS: 2,700 shares reported 2025-12-31; 2,774 shares reported 2026-03-31.
- ADAR1 Capital Management, LLC: 50,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- EVENTIDE ASSET MANAGEMENT, LLC: 2,549,019 shares reported 2025-12-31; 2,549,019 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
46 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Immix Biopharma, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-12-23 · Hsu Jason: Larger than 40 of the 41 other insider purchases of Common Stock on file. SEC filing
- 2023-12-11 · Hsu Jason: Larger than 39 of the 41 other insider purchases of Common Stock on file. SEC filing
- 2023-09-12 · Hsu Jason: Larger than 38 of the 41 other insider purchases of Common Stock on file. SEC filing
- 2021-12-20 · Hsu Jason: Larger than all 41 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-12-10–2025-12-10: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-09-16–2025-09-17: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-06-18–2025-06-18: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-08-16–2024-08-22: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2024-06-04–2024-06-07: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-05-14–2024-05-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-09-08–2023-09-15: 7 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2023-09-07–2023-09-14: 7 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2023-09-05–2023-09-12: 7 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2023-08-31–2023-09-07: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2022-11-14–2022-11-14: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2021-12-17–2021-12-20: 6 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-10 | Morris Gabriel S · CFO | Common Stock | P — Open market or private purchase | +770 | 6.58 | SEC filing |
| 2025-12-10 | Rachman Ilya M · CEO and Chairman | Common Stock | P — Open market or private purchase | +746 | 6.67 | SEC filing |
| 2025-09-17 | Rachman Ilya M · CEO and Chairman | Common Stock | P — Open market or private purchase | +2,500 | 2.02 | SEC filing |
| 2025-09-16 | Morris Gabriel S · CFO | Common Stock | P — Open market or private purchase | +2,600 | 1.97 | SEC filing |
| 2025-06-18 | Morris Gabriel S · CFO | Common Stock | P — Open market or private purchase | +2,225 | 2.28 | SEC filing |
| 2025-06-18 | Rachman Ilya M · CEO and Chairman | Common Stock | P — Open market or private purchase | +2,178 | 2.30 | SEC filing |
| 2024-12-23 | Hsu Jason · Director | Common Stock | P — Open market or private purchase | +40,000 | 2.19 | SEC filing |
| 2024-12-20 | Hsu Jason · Director | Common Stock | P — Open market or private purchase | +7,700 | 2.17 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-22 | Ng Carey · Director | Common Stock | A — Grant, award, or other acquisition | +6,250 | SEC filing |
| 2026-05-22 | CHANG NANCY T · Director | Common Stock | A — Grant, award, or other acquisition | +6,250 | SEC filing |
| 2026-05-22 | Marquet Magda · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +12,500 | SEC filing |
| 2026-05-22 | Adams Helen C. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +12,500 | SEC filing |
| 2026-05-22 | Marquet Magda · Director | Common Stock | A — Grant, award, or other acquisition | +6,250 | SEC filing |
| 2026-05-22 | Hsu Jason · Director | Common Stock | A — Grant, award, or other acquisition | +6,250 | SEC filing |
| 2026-05-22 | CHANG NANCY T · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +12,500 | SEC filing |
| 2026-05-22 | BUCHAN JANE · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +12,500 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.